GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAY) » Definitions » Intrinsic Value: Projected FCF

Elekta AB (Elekta AB) Intrinsic Value: Projected FCF : $3.96 (As of May. 05, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Elekta AB Intrinsic Value: Projected FCF?

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.

As of today (2024-05-05), Elekta AB's Intrinsic Value: Projected FCF is $3.96. The stock price of Elekta AB is $7.07. Therefore, Elekta AB's Price-to-Intrinsic-Value-Projected-FCF of today is 1.8.

The historical rank and industry rank for Elekta AB's Intrinsic Value: Projected FCF or its related term are showing as below:

EKTAY' s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 1.17   Med: 2.08   Max: 3.07
Current: 1.79

During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Elekta AB was 3.07. The lowest was 1.17. And the median was 2.08.

EKTAY's Price-to-Projected-FCF is ranked worse than
52.44% of 349 companies
in the Medical Devices & Instruments industry
Industry Median: 1.7 vs EKTAY: 1.79

Elekta AB Intrinsic Value: Projected FCF Historical Data

The historical data trend for Elekta AB's Intrinsic Value: Projected FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB Intrinsic Value: Projected FCF Chart

Elekta AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Intrinsic Value: Projected FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.50 5.36 7.20 5.74 4.78

Elekta AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Intrinsic Value: Projected FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.08 4.78 3.82 3.72 4.14

Competitive Comparison of Elekta AB's Intrinsic Value: Projected FCF

For the Medical Instruments & Supplies subindustry, Elekta AB's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elekta AB's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's Price-to-Projected-FCF distribution charts can be found below:

* The bar in red indicates where Elekta AB's Price-to-Projected-FCF falls into.



Elekta AB Intrinsic Value: Projected FCF Calculation

Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.

The details of how we calculate the intrinsic value of stocks are described in detail here.

This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + 0.8 * Total Stockholders Equity (most recent) ) / Shares Outstanding (Diluted Average)

In the case of negative Total Stockholders Equity, the following formula is used (see Explanation section below for the reason):

Intrinsic Value: Projected FCF = ( Growth Multiple * Free Cash Flow (6 year avg) + Total Stockholders Equity (most recent) / 0.8 ) / Shares Outstanding (Diluted Average)


Add all the Free Cash Flow together and divide 6 will get Elekta AB's Free Cash Flow(6 year avg) = $90.85.

Elekta AB's Intrinsic Value: Projected FCF for today is calculated as

Intrinsic Value: Projected FCF=(Growth Multiple*Free Cash Flow (6 year avg)+Total Stockholders Equity (Jan24)*0.8)/Shares Outstanding (Diluted Average)
=(9.5203515959648*90.85168+989.159*0.8)/382.000
=4.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elekta AB  (OTCPK:EKTAY) Intrinsic Value: Projected FCF Explanation

The growth multiple is capped between 8.35 and 17.74.

Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.

Elekta AB's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as

Price-to-Intrinsic-Value-Projected-FCF=Share Price/Intrinsic Value: Projected FCF
=7.07/4.3357778447227
=1.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elekta AB Intrinsic Value: Projected FCF Related Terms

Thank you for viewing the detailed overview of Elekta AB's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Elekta AB (Elekta AB) Business Description

Address
Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.

Elekta AB (Elekta AB) Headlines

From GuruFocus

Invitation to Elekta's Capital Markets Day 2021

By PRNewswire PRNewswire 05-20-2021

Elekta to appoint Tobias H�ggl�v as Chief Financial Officer

By PRNewswire PRNewswire 01-07-2022

Report from the Annual General Meeting 2021 in Elekta

By PRNewswire PRNewswire 08-25-2021

Elekta appoints Johan Adeb�ck as Chief Financial Officer

By PRNewswire PRNewswire 02-25-2021

Elekta's new sustainability-linked bond oversubscribed

By PRNewswire PRNewswire 12-03-2021

Elekta establishes a framework for sustainability-linked bonds

By PRNewswire PRNewswire 10-29-2021

Elekta wins lawsuit against Livian GmbH

By PRNewswire PRNewswire 03-08-2021